WEALTH ENHANCEMENT ADVISORY SERVICES, LLC

Position in IPSC — Century Therapeutics, Inc.

CIK 1632972 PLYMOUTH, MN

Position in IPSC

as of Jun 30, 2026 · filed Jul 15, 2026 Compact

Position Value

$190,683

+$14,862 QoQ

Shares Held

77,830

+0.0% QoQ

Ownership

0.043%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

#50

of 98 holders

Holding Since

Sep 2023

12 quarters on record

Voting authority Sole 0% Shared 0% None 100%

Healthcare · as of Jun 30, 2026

WEALTH ENHANCEMENT ADVISORY SERVICES, LLC holds $166,117,226 across 147 Biotechnology names. IPSC ranks #92 (0.1% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	VRTX	Vertex Pharmaceuticals Inc / Ma	45,889	$22,794,442
2	REGN	Regeneron Pharmaceuticals, Inc.	33,880	$21,125,535
3	INCY	Incyte Corp	151,505	$17,174,606
4	EXEL	Exelixis, Inc.	207,728	$11,302,480
5	RPRX	Royalty Pharma plc	179,888	$10,086,320
6	CORT	Corcept Therapeutics Inc	76,278	$6,632,372
7	HALO	Halozyme Therapeutics, Inc.	70,797	$5,541,281
8	AXSM	Axsome Therapeutics, Inc.	19,919	$4,875,573

12 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$190,683	77,830	+0.0%	Shares	Sole	2026-07-15
2026-03-31	$175,821	77,797	0.0%	Shares	Sole	2026-04-08
2025-12-31	$77,408	77,797	-0.1%	Shares	Sole	2026-01-08
2025-09-30	$38,770	77,853	-4.2%	Shares	Sole	2025-10-29
2025-06-30	$45,417	81,247	-4.5%	Shares	Sole	2025-07-10
2025-03-31	$40,499	85,083	+8.2%	Shares	Sole	2025-04-16
2024-12-31	$79,439	78,653	+0.6%	Shares	Sole	2025-03-17
2024-09-30	$133,739	78,210	-0.0%	Shares	Sole	2024-10-24
2024-06-30	$199,496	78,234	+0.0%	Shares	Sole	2024-07-16
2024-03-31	$326,938	78,215	0.0%	Shares	Sole	2024-04-15
2023-12-31	$259,673	78,215	+159.4%	Shares	Sole	2024-01-30
2023-09-30	$60,302	30,151	—	Shares	Sole	2023-11-13
No filing history on record for this holder in this stock.